About this trial
The goal of this clinical trial is to describe the cardiac and systemic inflammatory adaptations specific to women practicing ultra-endurance sports.
The objectives are to:
* Improve the understanding of cardiac and systemic inflammatory adaptations specific to women participating in ultra-endurance sports. * Assess the relationship between observed cardiac and systemic inflammatory alterations and the relative levels of estrogen, testosterone, and progesterone. * Describe the vascular adaptations specific to women participating in ultra-endurance sports. * Examine the influence of defense mechanisms on the emotional dynamics observed during and after an ultra-endurance race.
Eligibility criteria
Qualifiers
Must have a Global Positioning System watch during the race;
"Ecotrail de Paris Ile France©" (=a trail running race in the Paris region, it is not possible to translate; it is a registered trademark) 80 kilometers;
Or "la 6000D©" 69 kilometers;
Medical certificate stating no contraindications to competitive running, dated less than 12 months prior to the race;
Disqualifiers
Refusal or linguistic or mental incapacity to sign the informed consent form;
Person under guardianship (conservatorship, curators, or legal protection) or deprived of liberty;
Person not affiliated with a social security scheme;
Pregnant woman;
Trial design
Treatments tested in this trial
- Echocardiography
- Arterial ultrasound
- Blood sampling
- Scales and questionnaire
- Vital signs
- Urinary test